Labcorp (LH)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$283.76-0.22%
Close 2026-07-07 · 1-day change
Reading LH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LH free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading LH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LH free→QuarterlyIQ Insights · LH
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition.
Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on April 9, 2026, that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on June 11, 2026, to stockholders of record as of the close of business on May 29, 2026 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
Entry into a Material Definitive Agreement. On March 20, 2026 (the “Closing Date”), Labcorp Holdings Inc. (the “Company”), as parent guarantor, and Laboratory Corporation of America Holdings (“LCAH”), as borrower, entered into a Term Loan Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent, Wells Fargo Securities, LLC, as joint lead arranger and sole bookrunner, PNC Capital Markets LLC, as joint lead arranger, PNC Bank…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Results of Operations and Financial Condition
Director — John H. Sampson, M.D., Ph.D.: Dr. Sampson was appointed as a new Director and to the Quality and Compliance Committee.
Entry into a Material Definitive Agreement. On January 28, 2026, Labcorp Holdings Inc. (the “Company”) amended its receivables purchase agreement (as amended, the “Receivables Purchase Agreement”) by entering into the Second Amendment to the Receivables Purchase Agreement (the “RPA Amendment”), among Labcorp Receivables LLC (“Labcorp Receivables”), Laboratory Corporation of America Holdings, PNC Bank, National Association, as administrative agent and the other parties thereto and acknowledged…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on January 14, 2026 that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on March 12, 2026, to stockholders of record as of the close of business on February 27, 2026 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
Executive Vice President, President, Diagnostics Laboratories, and Chief Operations Officer — Mark Schroeder: Mark Schroeder intends to retire, effective April 1, 2026.
Director — Dr. D. Gary Gilliland: Dr. D. Gary Gilliland retired from the Board of Directors.
Director — Victor Bulto: Victor Bulto was appointed as a member of the Board.
Results of Operations and Financial Condition
Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on October 8, 2025 that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on December 11, 2025, to stockholders of record as of the close of business on November 26, 2025 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
Results of Operations and Financial Condition
Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on July 10, 2025 that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on September 11, 2025, to stockholders of record as of the close of business on August 28, 2025 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth in
Entry into a Material Definitive Agreement On June 27, 2025 (the “Closing Date”), Labcorp Holdings Inc. (the “Company”), as parent guarantor, and Laboratory Corporation of America Holdings (“LCAH”), as borrower, entered into a Fourth Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”), as administrative agent, and the other lenders party thereto, which provides for a $1,000,000,000 senior unsecured revolving credit facility (including…
The filing is about the approval of compensation plans, not a management change.
Results of Operations and Financial Condition
Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on April 10, 2025 that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on June 11, 2025, to stockholders of record as of the close of business on May 29, 2025 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
Results of Operations and Financial Condition
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Entry into a Material Definitive Agreement. On January 31, 2025, Labcorp Holdings Inc. (the “Company”) amended its receivables purchase agreement (as amended, the “Receivables Purchase Agreement”) by entering into the First Amendment to the Receivables Purchase Agreement (the “RPA Amendment”), among Labcorp Receivables LLC (“Labcorp Receivables”), Laboratory Corporation of America Holdings, PNC Bank, National Association, as administrative agent and the other parties party thereto and acknowl…
Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on January 8, 2025 that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on March 12, 2025, to stockholders of record as of the close of business on February 27, 2025 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.